Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Source And Potency Of Stem Cells01:27

Source And Potency Of Stem Cells

4.8K
Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...
4.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Artificial intelligence in immunotherapy: revolutionizing diagnostic and therapeutic applications in cancer and autoimmune diseases.

Clinical and experimental medicine·2026
Same author

Knowledge, attitude, and practice of physicians toward the management of diabetic ketoacidosis.

Frontiers in clinical diabetes and healthcare·2026
Same author

Artificial Intelligence in Drug Discovery: Integrative Advances From Data to Therapeutic Innovation.

Drug development research·2026
Same author

Role of ncRNAs in Neurological Disorders and Cardiovascular Diseases.

Experientia supplementum (2012)·2026
Same author

Angiotensin converting enzyme inhibitors (ACEIs) for anthracycline-induced cardiotoxicity: a systematic review and meta-analysis of randomized controlled trials.

Annals of Saudi medicine·2025
Same author

Living bio-drug therapies using mesenchymal stem cells and exosomes for mechanically ventilated patients with acute respiratory distress syndrome: A systematic review and meta-analysis.

World journal of stem cells·2025
Same journal

Sclerostin silencing in human umbilical cord mesenchymal stem cells enhances bone regeneration <i>via</i> Wnt pathway activation.

World journal of stem cells·2026
Same journal

Targeting mitochondrial quality control in osteoarthritis with GrpE-like 1-loaded synovial mesenchymal stromal/stem cell small extracellular vesicles.

World journal of stem cells·2026
Same journal

Epiregulin enhances periodontal tissue regeneration by promoting bone marrow mesenchymal stem cell functions under inflammatory niches.

World journal of stem cells·2026
Same journal

Correction to "Synergism of calycosin and bone marrow-derived mesenchymal stem cells to combat podocyte apoptosis to alleviate adriamycin-induced focal segmental glomerulosclerosis".

World journal of stem cells·2026
Same journal

GATA2 deficiency exacerbates chronic liver injury <i>via</i> disrupting hepatocyte death-regeneration balance: Clinical, histopathological, and molecular evidence.

World journal of stem cells·2026
Same journal

Therapeutic applications of mesenchymal stem cell-derived extracellular vesicles in pain management: A narrative review of emerging evidence and future directions.

World journal of stem cells·2026
查看所有相关文章

相关实验视频

Updated: Jun 22, 2025

Author Spotlight: Advancements in iPSCs and Genetic Disease Research
06:24

Author Spotlight: Advancements in iPSCs and Genetic Disease Research

Published on: October 20, 2023

1.1K

启动介质干细胞以开发"超级干细胞".

Khawaja Husnain Haider1

  • 1Department of Basic Sciences, Sulaiman AlRajhi University, AlQaseem 52736, Saudi Arabia. kh.haider@sr.edu.sa.

World journal of stem cells
|July 1, 2024
PubMed
概括
此摘要是机器生成的。

开发"超级干细胞"涉及预治疗策略,以增强干细胞和治疗特性. 结合方法,比如使用介质干细胞 (MSCs) 与细胞因子和缺氧,显示出先进的再生医学的前景.

关键词:
细胞存活率 细胞存活率细胞疗法是一种细胞疗法.预处理的前期处理预先条件的形成干细胞是一种干细胞.超级干细胞是一种超级干细胞.

更多相关视频

Author Spotlight: Isolation and Identification of Mesenchymal Stem Cells Derived from Adipose Tissue of Sprague Dawley Rats
10:50

Author Spotlight: Isolation and Identification of Mesenchymal Stem Cells Derived from Adipose Tissue of Sprague Dawley Rats

Published on: April 7, 2023

3.2K
Magnetic-Activated Cell Sorting Strategies to Isolate and Purify Synovial Fluid-Derived Mesenchymal Stem Cells from a Rabbit Model
10:20

Magnetic-Activated Cell Sorting Strategies to Isolate and Purify Synovial Fluid-Derived Mesenchymal Stem Cells from a Rabbit Model

Published on: August 10, 2018

11.2K

相关实验视频

Last Updated: Jun 22, 2025

Author Spotlight: Advancements in iPSCs and Genetic Disease Research
06:24

Author Spotlight: Advancements in iPSCs and Genetic Disease Research

Published on: October 20, 2023

1.1K
Author Spotlight: Isolation and Identification of Mesenchymal Stem Cells Derived from Adipose Tissue of Sprague Dawley Rats
10:50

Author Spotlight: Isolation and Identification of Mesenchymal Stem Cells Derived from Adipose Tissue of Sprague Dawley Rats

Published on: April 7, 2023

3.2K
Magnetic-Activated Cell Sorting Strategies to Isolate and Purify Synovial Fluid-Derived Mesenchymal Stem Cells from a Rabbit Model
10:20

Magnetic-Activated Cell Sorting Strategies to Isolate and Purify Synovial Fluid-Derived Mesenchymal Stem Cells from a Rabbit Model

Published on: August 10, 2018

11.2K

科学领域:

  • 细胞和分子生物学 细胞和分子生物学
  • 再生医学是一种再生医学.
  • 免疫学 免疫学 免疫学

背景情况:

  • 目前的干细胞预治疗方法,包括物理,遗传和药理方法,有局限性,并且往往是非组合性的.
  • 这项工作建立在之前的研究基础上,强调了治疗前策略的重要性,以改善干性和免疫调节功能.
  • 现有的协议往往无法利用结合不同预治疗方式的协同潜力.

研究的目的:

  • 探索治疗前策略在增强干细胞特性方面的意义.
  • 专注于增强干性,免疫调节和免疫抑制功能.
  • 通过优化预处理引入开发"超级干细胞"的概念.

主要方法:

  • 审查和阐述各种干细胞预处理方法 (物理,生长因子,遗传,化学,药理).
  • 专注于组合预治疗方案的复杂性.
  • 讨论在预治疗策略中使用促炎性细胞因子和缺氧.

主要成果:

  • 治疗前的策略可以显著提高干细胞的干性,免疫调节和免疫抑制特性.
  • 组合性预处理方案,特别是对于介质干细胞 (MSCs),对于开发增强细胞群至关重要.
  • 预计"超级MSC"的发展将通过机械的理解和多方策略来实现.

结论:

  • 预计一个明确的,多方面结合式预处理策略将创造"超级MSC".
  • 这种方法有可能在临床环境中彻底改变基于MSC的治疗方法.
  • 标准化协议可以适应各种干细胞,为各种临床应用创造"超级干细胞".